Control of measles and rubella through use of attenuated vaccines.
A summary report of the current status of morbidity and mortality associated with measles and rubella vis á vis immunization practices in the United States since these vaccines were licensed in 1963 (measles) and 1969 (rubella) is presented.
D002648:Child; D005544:Forecasting; D006801:Humans; D007109:Immunity; D008004:Licensure; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000302:isolation & purification / Q000627:therapeutic use*; D013344:Subacute Sclerosing Panencephalitis / Q000209:etiology; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects / Q000302:isolation & purification
D008458:Measles Vaccine; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated